Recursion Pharmaceuticals, Inc. RXRX Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s shares (diluted)?
- Recursion Pharmaceuticals, Inc. (RXRX) reported shares (diluted) of 529.3M in Q1 2026.
- How has Recursion Pharmaceuticals, Inc.'s shares (diluted) changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s shares (diluted) increased by 31.4% year-over-year, from 402.8M to 529.3M.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s shares (diluted)?
- Over 4 years (2021 to 2025), Recursion Pharmaceuticals, Inc.'s shares (diluted) has grown at a 39.3% compound annual growth rate (CAGR), from 455.3M to 1.7B.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.